Page last updated: 2024-10-27

flumazenil and Cancer of Ovary

flumazenil has been researched along with Cancer of Ovary in 2 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Provencio, M1
Espinosa, R1
Sánchez, A1
España, P1
Díez, O1
Doménech, M1
Alonso, MC1
Brunet, J1
Sanz, J1
Cortés, J1
del Río, E1
Baiget, M1

Other Studies

2 other studies available for flumazenil and Cancer of Ovary

ArticleYear
Flumazenil in the treatment of dizziness and vegetative symptoms after intravenous infusion of paclitaxel.
    Onkologie, 2008, Volume: 31, Issue:4

    Topics: Antidotes; Antineoplastic Agents, Phytogenic; Dizziness; Female; Flumazenil; Humans; Infusions, Intr

2008
Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population.
    Human genetics, 1998, Volume: 103, Issue:6

    Topics: Adult; Breast Neoplasms; Female; Genes, BRCA1; Genetic Markers; Humans; Jews; Mutation; Ovarian Neop

1998